MUCINEX Drug Patent Profile
✉ Email this page to a colleague
When do Mucinex patents expire, and when can generic versions of Mucinex launch?
Mucinex is a drug marketed by Rb Hlth and is included in three NDAs.
The generic ingredient in MUCINEX is dextromethorphan hydrobromide; guaifenesin. There are twenty-three drug master file entries for this compound. Sixty-three suppliers are listed for this compound. Additional details are available on the dextromethorphan hydrobromide; guaifenesin profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MUCINEX?
- What are the global sales for MUCINEX?
- What is Average Wholesale Price for MUCINEX?
Summary for MUCINEX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 9 |
Raw Ingredient (Bulk) Api Vendors: | 122 |
Clinical Trials: | 16 |
Patent Applications: | 3,054 |
Drug Prices: | Drug price information for MUCINEX |
Drug Sales Revenues: | Drug sales revenues for MUCINEX |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for MUCINEX |
What excipients (inactive ingredients) are in MUCINEX? | MUCINEX excipients list |
DailyMed Link: | MUCINEX at DailyMed |
Recent Clinical Trials for MUCINEX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
American Health Research | Phase 4 |
Vitaccess Ltd | Phase 4 |
Massachusetts Eye and Ear Infirmary | N/A |
Pharmacology for MUCINEX
Drug Class | Expectorant |
Physiological Effect | Decreased Respiratory Secretion Viscosity Increased Respiratory Secretions |
Paragraph IV (Patent) Challenges for MUCINEX
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
MUCINEX | Extended-release Tablets | guaifenesin | 600 mg and 1.2 gm | 021282 | 1 | 2006-06-09 |
US Patents and Regulatory Information for MUCINEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rb Hlth | MUCINEX | guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 021282-002 | Dec 18, 2002 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Rb Hlth | MUCINEX D | guaifenesin; pseudoephedrine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021585-001 | Jun 22, 2004 | OTC | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Rb Hlth | MUCINEX | guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 021282-001 | Jul 12, 2002 | OTC | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Rb Hlth | MUCINEX D | guaifenesin; pseudoephedrine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021585-002 | Jun 22, 2004 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Rb Hlth | MUCINEX DM | dextromethorphan hydrobromide; guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 021620-001 | Apr 29, 2004 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Rb Hlth | MUCINEX DM | dextromethorphan hydrobromide; guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 021620-002 | Apr 29, 2004 | OTC | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MUCINEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Rb Hlth | MUCINEX | guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 021282-002 | Dec 18, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Rb Hlth | MUCINEX | guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 021282-001 | Jul 12, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Rb Hlth | MUCINEX | guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 021282-001 | Jul 12, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Rb Hlth | MUCINEX | guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 021282-001 | Jul 12, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Rb Hlth | MUCINEX | guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 021282-002 | Dec 18, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Rb Hlth | MUCINEX | guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 021282-002 | Dec 18, 2002 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MUCINEX
See the table below for patents covering MUCINEX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Cyprus | 1108166 | ⤷ Sign Up | |
Eurasian Patent Organization | 200401369 | ⤷ Sign Up | |
European Patent Office | 1276467 | FORMULATION ET COMPRIMÉS À LIBÉRATION SOUTENUE DE GUAIFENESINE (GUAIFENESIN SUSTAINED RELEASE FORMULATION AND TABLETS) | ⤷ Sign Up |
New Zealand | 561044 | Bi-layered modified release tablets for sustained release of guaifenesin combination drugs | ⤷ Sign Up |
Germany | 60133538 | ⤷ Sign Up | |
New Zealand | 521959 | Guaifenesin sustained release formulation and tablets | ⤷ Sign Up |
European Patent Office | 1503739 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |